Template:Prenatal Diagnosis terms: Difference between revisions

From Embryology
No edit summary
Line 14: Line 14:


'''prenatal screening specificity''' - The probability of testing negative on a prenatal screening test if the congenital anomaly is absent.
'''prenatal screening specificity''' - The probability of testing negative on a prenatal screening test if the congenital anomaly is absent.
==External Links==
{{External Links}}
* '''WHO''' - Oladapo OT. Amniocentesis and chorionic villus sampling for prenatal diagnosis: RHL commentary (last revised: 1 April 2009). [http://apps.who.int/rhl/pregnancy_childbirth/fetal_disorders/prenatal_diagnosis/CD003252_Oladapot_com/en/index.html The WHO Reproductive Health Library]; Geneva: World Health Organization.

Revision as of 15:36, 18 August 2011

Prenatal Diagnosis Terms

false negative rate - The proportion of pregnancies that will test negative given that the congenital anomaly is present.

false positive rate - The proportion of pregnancies that will test positive given that the congenital anomaly is absent.

negative predictive value - The probability that a congenital anomaly is absent given that the prenatal screening test is negative.

positive predictive value - The probability that a congenital anomaly is present given that the prenatal screening test is positive.

pre-implantation genetic diagnosis - (PGD) a screening procedure for embryos produced through in vitro fertilisation (IVF) for genetic diseases that would generate developmental abnormalities or serious postnatal diseases.

prenatal screening sensitivity - (detection rate) The probability of testing positive on a prenatal screening test if the congenital anomaly is present.

prenatal screening specificity - The probability of testing negative on a prenatal screening test if the congenital anomaly is absent.